recent articles
Diagnosing pathological cancer is often a challenge, even for the most skilled clinicians. Many forms of cancer do not exhibit noticeable symptoms until the infection has progressed too far to treat effectively. Monoclonal antibodies are...
Number of patients eligible for genome-driven oncology therapy is increasing, but the percentage who reportedly benefit from the therapy remains at less than 5% Advances in precision medicine in oncology (precision oncology) are fueling...
Advisory Board Applauds On-Demand Approach of OptraSCAN
- Anatomic Pathology
- Business
- Clinical Laboratories
- Clinical Pathology
- Cloud Computing
- Current Affairs
- Data Management
- Device Manufacturers
- Digital Pathology News
- Education
- File format
- Image Analysis
- Informatics
- Laboratory Informatics
- Laboratory Management & Operations
- Pathology News
- Storage
- TeleHealth
- Vendor products
- Web/Tech
- Whole slide
OptraSCAN has given tissuepathology.com a rare insight into their advisory board discussions as to what their thought leaders think is important in the digital pathology space for the market. OptraSCAN is of course the first On-Demand...
Fierce Healthcare (5/2, Sweeney) reports on a Medscape survey finding that among oncologists, about 70% “believe genetic testing is very important or extremely important to oncology, but 55% also say genomic testing is overpromoted.” One...